Pancreatic Cancer Research

ResearcherShanghai Medical College of Fudan UniversityActive in the last 2 years

Lixia Yi

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0001-7642-3139; OpenAlex author ID A5103156099. Sources: OpenAlex.

Their work

Papers
2
Trials
0
Grants
0
Labs led
0
Collaborators
12
Papers, trials and grants by year

2024: 1 paper · 2025: none · 2026: 1 paper

Papers 2

  1. Luteolin Triggers Pyroptosis in Pancreatic Ductal Adenocarcinoma by Inhibiting Mitochondrial Fission through the RAS/ERK/DRP1 Pathway. Co-author DOI 10.1142/s0192415x26500606↗
  2. Clinical and biomarker analyses of SHR-1701 combined with famitinib in patients with previously treated advanced biliary tract cancer or pancreatic ductal aden… Co-author DOI 10.1038/s41392-024-02052-3↗

Closest collaborators

The 12 strongest of 12 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Waimei Si · 2 shared papers, 2024–2026 · strength 0.49
  2. Yuan Zhang · 1 shared paper, 2026 · strength 0.30
  3. Zhen Chen · 1 shared paper, 2026 · strength 0.30
  4. He Ba · 1 shared paper, 2026 · strength 0.30
  5. Xin Li · 1 shared paper, 2026 · strength 0.30
  6. Peiwen Yang · 1 shared paper, 2026 · strength 0.30
  7. Linjie Ruan · 1 shared paper, 2026 · strength 0.30
  8. Zhouyu Ning · 1 shared paper, 2024 · strength 0.18
  9. Jing Xie · 1 shared paper, 2024 · strength 0.18
  10. Yifan Yang · 1 shared paper, 2024 · strength 0.18
  11. Xiaoyan Zhu · 1 shared paper, 2024 · strength 0.18
  12. Zhiqiang Meng · 1 shared paper, 2024 · strength 0.18

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.